GlaxoSmithKline Plc
Last updated on 2017-03-21T20:07+0300.
About this image
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|
| Names | Lang | Count |
|---|---|---|
| Glaxosmithkline Plc | EN | 100.00% |
| Type | Entity Name | Count |
|---|---|---|
 | GlaxoSmithKline | 10.62% |
| Inc | 9.72% |
| Pfizer Inc | 5.91% |
| AstraZeneca PLC | 4.01% |
| Five Forces | 3.91% |
| Novartis | 3.21% |
| SA | 2.51% |
| World Health Organization | 2.00% |
| Roche Holding AG | 1.70% |
| Reuters Group | 1.60% |
| Abbott Laboratories | 1.50% |
| Pharmaceuticals Inc | 1.50% |
| Eli Lilly | 1.50% |
| Roche Ltd | 1.30% |
| Drug Administration | 1.30% |
 | Table | 1.10% |
| Teva Pharmaceuticals | 1.10% |
| Bristol Myers Squibb | 1.00% |
| Oxford University | 1.00% |
| Donald Trump | 0.90% |
| British | 0.80% |
| European Union | 0.80% |
| Strategy | 0.70% |
| Laura Wood | 0.60% |
| Bill Berkrot | 0.60% |
| Serum Institute | 0.60% |
| Saudi | 0.60% |
| Centers for Disease Control and Prevention | 0.60% |
| Laboratories Ltd | 0.50% |
| Boehringer Ingelheim | 0.50% |
| Type | Entity Name | Score |
|---|---|---|
| GlaxoSmithKline | 0.1061 |
| Five Forces | 0.038 |
| AstraZeneca PLC | 0.0372 |
| Novartis | 0.0317 |
| Roche Holding AG | 0.017 |
| SA | 0.0167 |
| Abbott Laboratories | 0.0149 |
| Eli Lilly | 0.0143 |
| Inc | 0.014 |
| Pharmaceuticals Inc | 0.0134 |
| Roche Ltd | 0.0131 |
| Teva Pharmaceuticals | 0.0107 |
| Bristol Myers Squibb | 0.0102 |
| Table | 0.0085 |
| Margaret Wurth | 0.0066 |
| Bill Berkrot | 0.0061 |
| Laura Wood | 0.0059 |
| Oxford University | 0.0057 |
| Serum Institute | 0.0056 |
| Laboratories Ltd | 0.0051 |
| Takeda Pharmaceutical | 0.0051 |
| Pfizer Inc | 0.005 |
| Boehringer Ingelheim | 0.005 |
| Caroline Humer | 0.0049 |
| Strategy | 0.0043 |
| Fresenius AG | 0.0042 |
| Product Development | 0.004 |
| Takeda Pharmaceutical Co | 0.004 |
| CSL Ltd | 0.004 |
| Unilever Group | 0.004 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Friday, December 4, 2020
8:25:00 PM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 